U.S. Seeks as Much as $18.1 Billion From Purdue Pharma
The US Department of Justice is demanding oxycontin maker Purdue Pharma pay as much as eighteen point one billion in penalties as part of its bankruptcy reorganization plan. The Wall Street Journal reports on the civil side. The DOJ is seeking two point eight billion, which could be tripled under the law for tax dollars spent battling the US opioid epidemic, as well as kickbacks to doctors and pharmacies, and transferring cash to hide money from creditors on the criminal side. Federal prosecutors want purdue to pay a six point, two, billion fine and the forfeiture of potentially three and a half billion more over marketing and distribution that violated criminal statutes including anti kickback laws misbranding under the Food Drug and Cosmetic Act and conspiracy.